Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.61 Analyst target: $30.00 Upside: 1763.35%
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company is headquartered in Ramat Gan, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.